Streetbeat News

Assets

MRNA

A large bearish position on Moderna (NASDAQ:MRNA) has been noticed, with 15 uncommon options trades spotted. The sentiment of these big-money traders is split between 46% bullish and 53% bearish. Whales have been targeting a price range from $100.0 to $165.0 for Moderna over the last 3 months. UBS upgraded its action to Buy with a price target of $191, while Morgan Stanley maintained their Equal-Weight rating with a price target of $128.

Portfolio Pulse from Benzinga Insights

July 12, 2023 | 5:19 pm

LLY

Eli Lilly (NYSE:LLY) has outperformed the market over the past 10 years by 13.85% on an annualized basis, producing an average annual return of 24.13%. If an investor had bought $1000 of LLY stock 10 years ago, it would be worth $8,596.53 today.

Portfolio Pulse from Benzinga Insights

July 12, 2023 | 5:00 pm

RSG

Over the past 15 years, Republic Servs (NYSE:RSG) has outperformed the market by 1.89% on an annualized basis, producing an average annual return of 10.72%. If an investor had bought $1000 of RSG stock 15 years ago, it would be worth $4,765.81 today.

Portfolio Pulse from Benzinga Insights

July 12, 2023 | 5:00 pm

A large investor has taken a bullish stance on Sea (NYSE:SE), as evidenced by a significant position in the company's options. The overall sentiment of these big-money traders is split between 53% bullish and 46% bearish. The mean open interest for Sea options trades today is 3058.25 with a total volume of 6,923.00. The price of SE is up 3.3% at $61.06.

Portfolio Pulse from Benzinga Insights

July 12, 2023 | 4:49 pm

TGT

A significant amount of unusual options activity has been observed for Target Corporation (NYSE:TGT), with a majority of investors taking a bearish stance. The price range targeted by these investors over the last three months is between $125.0 and $190.0. TD Cowen has maintained their Outperform rating on Target, with a price target of $166.

Portfolio Pulse from Benzinga Insights

July 12, 2023 | 4:33 pm

SBUX

Over the past 10 years, Starbucks (NASDAQ:SBUX) has outperformed the market by 1.07% on an annualized basis, producing an average annual return of 11.34%. If an investor had bought $1000 of SBUX stock 10 years ago, it would be worth $2,922.48 today.

Portfolio Pulse from Benzinga Insights

July 12, 2023 | 4:30 pm

WST

West Pharmaceutical Servs (NYSE:WST) has outperformed the market over the past 20 years by 15.43% on an annualized basis, producing an average annual return of 23.28%. If an investor had bought $1000 of WST stock 20 years ago, it would be worth $60,931.68 today.

Portfolio Pulse from Benzinga Insights

July 12, 2023 | 4:30 pm

AGI

CDE

EGO

FNV

KGC

MUX

Shares of precious metals companies are trading higher as gold and silver prices increase due to a drop in the US dollar following soft June inflation data.

Portfolio Pulse from Benzinga Newsdesk

July 12, 2023 | 4:29 pm

AULT

HCTI

PRFX

RXRX

THTX

TTOO

US stocks traded higher with the S&P 500 gaining 1%. US crude oil inventories increased more than expected. Healthcare Triangle, Ault Alliance, and Recursion Pharmaceuticals saw significant stock increases due to various initiatives and collaborations. Theratechnologies, PainReform, and T2 Biosystems saw stock decreases due to weak sales and preliminary results.

Portfolio Pulse from Lisa Levin

July 12, 2023 | 4:13 pm

CMDY

USO

Economists predict a year-over-year increase of 0.4% for the U.S. producer price index (PPI) in June, down from 1.1% in May, marking the lowest level since September 2020. This is due to easing inflationary pressures, with consumer inflation in June decreasing to 3% year-on-year. The Bloomberg Commodity Index, tracked by the iShares Bloomberg Roll Select Commodity Strategy ETF (CMDY), rose 2.6% in June, while oil prices, tracked by the United States Oil Fund ETF (USO), increased by 3.7% in June 2023 but remained 33% below June 2022 levels.

Portfolio Pulse from Piero Cingari

July 12, 2023 | 4:10 pm